Cala ONE Device for Essential Tremor

计划入组 93 人 · 首次发布于 2015 年 12 月 14 日

A Pilot Study of the Cala ONE Device for Essential Tremor

计划入组 62 人 · 首次发布于 2017 年 5 月 12 日

Prospective Study for Symptomatic Relief of ET With Cala Therapy

计划入组 263 人 · 首次发布于 2018 年 7 月 24 日

CADA

rHCG (Unico Health)

rFSH (Unico Health)

CALA HEALTH, INC.

United States

Axcella Health

United States

Astrana Health

United States

Sensor-Based Digital Therapeutics Devices Market to Reach $590.9 Million by 2036, Driven by Regulatory Pathways and Payer Coverage

mHealth Intervention Improves Mental Health in Thyroid Cancer Patients

HEALIX Study Aims to Reduce Cervical Cancer Disparities Through Targeted Interventions